StonvexLoading…
StonvexStonvexStonvexCore line items from ALK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-21 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $4.14B | $3.30B | $14.24B | $10.61B | $6.84B |
Operating Income | Not available | $-279.00M | $303.00M | $228.00M | $80.00M |
Net Income | Not available | $-193.00M | $100.00M | $79.00M | $172.00M |
EPS (Diluted) | $-1.01 | $-1.69 | $0.83 | $0.65 | $0.05 |
Total Assets | Not available | $20.30B | $20.36B | $20.01B | $19.89B |
Total Liabilities | Not available | Not available | Not available | Not available | Not available |
Cash & Equivalents | Not available | $451.00M | $627.00M | $778.00M | $750.00M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available | Not available |
Shares Outstanding | Not available | 111.36M | 115.53M | 115.23M | 115.28M |